PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 29, 2026Orthopaedic Journal of Sports Medicine0 citationsOpen Access

Patellofemoral Bipolar Osteochondral Allograft Surgery Yields Similar Short- to Mid-term Outcomes As Unipolar Surgery: A Minimum 2-year Follow-up Study

View Full Paper
EAEdouard AugustinTMThomas MoranMAMyles Atkins

Key Points

  • This study aims to compare the outcomes of bipolar and unipolar patellofemoral osteochondral allograft transplantation over a minimum two-year follow-up period.
  • Retrospective review of 36 knees undergoing patellofemoral OCA transplantation from 2015 to 2022
  • Comparison of graft failure rates, reoperation rates, and patient-reported outcomes between groups
  • Statistical analyses included Fisher’s exact tests, Wilcoxon rank-sum tests, and Kaplan-Meier survivorship analysis.
  • Graft failure rates were similar: 4.17% in unipolar vs 8.3% in bipolar (p > 0.99)
  • Reoperation-free survival was non-significantly lower in bipolar patients at 4.7 years, showing 57% vs 92% in unipolar (p = 0.15)
  • Patient-reported outcomes improvements showed no significant differences across IKDC and KOOS scores.

Abstract

Objectives: While osteochondral allograft (OCA) transplantation for tibiofemoral chondral lesions has been extensively studied, there is limited literature on outcomes following patellofemoral (PF) OCA transplantation, especially for the treatment of bipolar PF chondral lesions. This study aimed to compare graft failure rates, reoperation, and patient-reported outcomes (PROs) between patients undergoing unipolar and bipolar PF OCA transplantation with a minimum follow-up of two years. Methods: A retrospective review of PF OCA transplantations between 2015-2022 at a single institution was performed. Those with concomitant tibiofemoral OCA transplantation or 0.99) and survivorship did not significantly differ ( p = 0.16), with 100% unipolar and 91.7% bipolar grafts surviving 2-4 years postoperatively ( Figure 1 ). Reoperation-free survival was non-significantly lower among bipolar patients (92% in unipolar and bipolar at 2 years, 92% vs 76% at 3 years, and 92% vs 57% at 4.7 years, p = 0.15). PRO improvements from baseline at final follow-up were similar ( Figure 2 ). No significant differences in IKDC ( p = 0.74), KOOS Pain ( p = 0.64), and KOOS Sports ( p = 0.33) MCID achievement were observed ( Figure 3 ). Conclusions: Bipolar and unipolar PF OCA transplantation both yielded excellent and comparable graft survivorship and clinically significant functional improvement at short- to mid-term follow-up.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Augustin et al. (2026) studied this question.

synapsesocial.com/papers/6a192f1bfab5b468c4418733https://doi.org/10.1177/2325967126s00048
Ask AI
Helpful
Bookmark
Share
View Full Paper